NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Oncolytics Biotech Inc (TSE: ONC)

 
ONC Technical Analysis
1.5
As on 31st Oct 2017 ONC Share Price closed @ 0.57 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.52 & Sell for SHORT-TERM with Stoploss of 0.57 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ONC Share Price

Open 0.54 Change Price %
High 0.57 1 Day 0.01 1.79
Low 0.54 1 Week 0.00 0.00
Close 0.57 1 Month -0.03 -5.00
Volume 112035 1 Year 0.31 119.23
52 Week High 1.13 | 52 Week Low 0.19
 
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
LSG 2.08 8.33%
TBE 0.03 0.00%
ECA 15.09 4.43%
SC 60.83 -0.44%
PRE 0.64 0.00%
ELD 1.62 -6.90%
MFC 25.94 -0.04%
CPG 10.61 4.53%
BBD-B 2.73 -1.09%
 
TSE Canada Top Gainers Stocks
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
GGA 0.06 20.00%
ANX 0.07 16.67%
ANX 0.07 16.67%
COM 2.27 14.07%
 
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
NXJ 2.35 -10.31%
NXJ 2.35 -10.31%
RN 0.09 -10.00%
RN 0.09 -10.00%
CTU-A 0.19 -9.52%
TNP 0.90 -9.09%
TNP 0.90 -9.09%
TNX 0.34 -8.11%
QEC 0.74 -7.50%
 
 
ONC
Daily Charts
ONC
Intraday Charts
Whats New @
Bazaartrend
ONC
Free Analysis
 
ONC Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.60
RESISTANCE0.59
SUPPORT0.55
SUPPORT0.54
SUPPORT0.00
SUPPORT0.00
 
ONC Target for Month May
4th UP TARGET0.82
3rd UP TARGET0.74
2nd UP TARGET0.69
1st UP TARGET0.64
1st DOWN TARGET0.5
2nd DOWN TARGET0.45
3rd DOWN TARGET0.4
4th DOWN TARGET0.32
 
ONC Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
ONC Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
ONC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ONC Address
ONC
1167 Kensington Crescent NW
Suite 210
Calgary, AB T2N 1X7
Canada
Phone: 403-670-7377
Fax: 403-283-0858
 
ONC Latest News
 
Your Comments and Response on Oncolytics Biotech Inc
 
ONC Business Profile
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic. Its cancer product is a potential therapeutic for tumours possessing an activated Ras pathway. The company was founded in 1998 and is headquartered in Calgary, Canada.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service